Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers quit by reducing withdrawal symptoms and cravings associated with tobacco dependence. The patch delivers a controlled release of nicotine over several hours, providing steady plasma levels.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures timely delivery and regulatory compliance across multiple regions.

Nicorette Invisipatch is a nicotine replacement therapy used in the management of tobacco dependence.

Smoking cessation: provides a steady nicotine supply to reduce cravings and withdrawal symptoms in adult smokers. Tobacco dependence: supports gradual reduction of nicotine intake as part of a quit‑plan. Relapse prevention: helps maintain abstinence by mitigating occasional urges after quitting.

Nicorette Invisipatch may cause a range of adverse reactions, most of which are mild and localized to the application site.

Common Side Effects: - Skin irritation at the patch site - Itching or redness - Sleep disturbance or vivid dreams - Nausea - Headache - Dizziness

Serious or Rare Side Effects: - Allergic reaction with rash, swelling or hives - Severe skin necrosis or ulceration - Rapid heart rate or palpitations - Low blood pressure (hypotension) - Chest pain

Before using Nicorette Invisipatch, consider the following precautions to ensure safe and effective therapy.

Cardiovascular assessment: evaluate for recent heart attack, uncontrolled angina, or severe hypertension. Non‑smokers and occasional smokers: avoid use, as nicotine exposure is unnecessary. Comprehensive quit plan: use the patch together with behavioral support and counseling. Pregnancy and breastfeeding: consult a healthcare professional, as safety data are limited. Children and pets: keep patches out of reach to prevent accidental exposure. Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine can interact with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may amplify nicotine’s cardiovascular effects. - Certain antihypertensive drugs (beta‑blockers, clonidine): nicotine can counteract blood‑pressure‑lowering actions. - Insulin or oral hypoglycemics: nicotine may affect glucose control, requiring dose adjustments.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): can increase nicotine plasma levels. - Warfarin: nicotine may alter anticoagulant metabolism. - Oral contraceptives: nicotine can reduce hormonal efficacy. - Antidepressants (SSRIs, tricyclics): monitor for enhanced side effects.